Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?

This paper reviews the use of hyperfractionated and/or accelerated radiation therapy in the curative treatment of non-small cell lung cancer, and explains the scientific rationale behind the development of these regimes. The indications, practicalities and economics of introducing them routinely are...

Descripción completa

Detalles Bibliográficos
Autores principales: Eakin, R. L., Saunders, M. I.
Formato: Texto
Lenguaje:English
Publicado: Ulster Medical Society 2000
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2449197/
https://www.ncbi.nlm.nih.gov/pubmed/11196724
_version_ 1782157319740588032
author Eakin, R. L.
Saunders, M. I.
author_facet Eakin, R. L.
Saunders, M. I.
author_sort Eakin, R. L.
collection PubMed
description This paper reviews the use of hyperfractionated and/or accelerated radiation therapy in the curative treatment of non-small cell lung cancer, and explains the scientific rationale behind the development of these regimes. The indications, practicalities and economics of introducing them routinely are addressed. Novel radiotherapy techniques are further discussed in the context of current developments and on-going clinical trials.
format Text
id pubmed-2449197
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Ulster Medical Society
record_format MEDLINE/PubMed
spelling pubmed-24491972008-07-10 Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand? Eakin, R. L. Saunders, M. I. Ulster Med J Research Article This paper reviews the use of hyperfractionated and/or accelerated radiation therapy in the curative treatment of non-small cell lung cancer, and explains the scientific rationale behind the development of these regimes. The indications, practicalities and economics of introducing them routinely are addressed. Novel radiotherapy techniques are further discussed in the context of current developments and on-going clinical trials. Ulster Medical Society 2000-11 /pmc/articles/PMC2449197/ /pubmed/11196724 Text en
spellingShingle Research Article
Eakin, R. L.
Saunders, M. I.
Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?
title Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?
title_full Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?
title_fullStr Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?
title_full_unstemmed Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?
title_short Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?
title_sort non-small cell lung cancer and chart (continuous hyperfractionated accelerated radiotherapy)--where do we stand?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2449197/
https://www.ncbi.nlm.nih.gov/pubmed/11196724
work_keys_str_mv AT eakinrl nonsmallcelllungcancerandchartcontinuoushyperfractionatedacceleratedradiotherapywheredowestand
AT saundersmi nonsmallcelllungcancerandchartcontinuoushyperfractionatedacceleratedradiotherapywheredowestand

Ejemplares similares